OOIR: Observatory of International Research

Papers

(The H4-Index of Schizophrenia Research is 31. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-01-01 to 2026-01-01.)

Article	Citations
Elevated triglycerides and low triiodothyronine: Key risk factors for coronary artery calcification in patients with schizophrenia	125
Substance use and self-poisoning in schizophrenia: 11-year findings from a national clinical survey of suicide in mental health patients in the UK	94
Effect of add-on tDCS therapy for auditory hallucinations on frequency and duration deviant mismatch negativity in schizophrenia	86
Exploring associations between trait symptoms and speech patterns in schizophrenia spectrum disorders: A mediation analysis	78
Everyday function in schizophrenia: The impact of aerobic endurance and skeletal muscle strength	71
Ethno-racial variation in psychotic experiences in the United States: Findings from the National Latino and Asian American Survey and the National Survey of American Life	69
Going the extra mile? The influence of Amisulpride on effort-based decisions	59
Searching for the “final proof” of schizophrenia	59
A 20-year review comparing the use of ‘schizophrenia’ and ‘psychosis’ in UK newspapers from 2000 to 2019: Implications for stigma reduction	52
Scrutinizing the increased mortality risk associated with the use of typical oral antipsychotics	49
A profile of high scores on the Peters delusion inventory and low engagement in pandemic-related health behaviors in a non-clinical sample	47
Shortening telomere is associated with psychotic dimensions in the general population	46
Comorbid psychosis in temporal lobe epilepsy is associated with auditory emotion recognition impairments	45
Effect of anticholinergic burden on brain activity during Working Memory and real-world functioning in patients with schizophrenia	44
Long-term safety and effectiveness of open-label lurasidone in antipsychotic-Naïve versus previously treated adolescents with Schizophrenia: A post-hoc analysis	43
Frequency of clinical appointments in subjects with emergent suicidal ideation	42
Electroconvulsive therapy in a patient with positive anti-NMDA receptor antibodies presenting with isolated psychiatric symptoms: A case report	42
Measurement invariance of the Revised-Green Paranoid Thought Scale across Black and White Americans	41
Association between initial clozapine titration and pneumonia risk among patients with schizophrenia in a Korean tertiary hospital	40
Associations between acceptance of the implausible bias, theory of mind and delusions in first-episode psychosis patients; A longitudinal study	40
Re-inventing the schizophrenia syndrome: The elusive “theory of everything”	39
The impact of daily social support on the associations between daily negative events and daily suspiciousness across different clinical stages of psychosis	39
Reply to Dyadic interaction in schizophrenia – A promising new avenue of investigation?	37
Can clozapine be used for treatment-refractory behavioral and psychological symptoms in dementia patients?	36
Construction of extra-large scale screening tools for risks of severe mental illnesses using real world healthcare data	36

Denial of anosognosia in schizophrenia	35
Exploring the conceptualisation, measurement, clinical utility and treatment of formal thought disorder in psychosis: A Delphi study	35
Meta-analysis of a family history of diabetes in schizophrenia	33
Recovery from leukopenia after discontinuation of clozapine does not exclude lymphoma	32
App for independence: A feasibility randomized controlled trial of a digital health tool for schizophrenia spectrum disorders	31
Testing two theories of social support benefits and implications for individuals with psychotic-like experiences	31
Exploring phenotypic overlap across schizotypy and autism spectrum conditions in American and Chinese young adults	31
Rethinking psychosis: Time to retire “organic”, “idiopathic” and “secondary”?	31
Comments on the manuscript: Arthur Schopenhauer: An underappreciated philosopher in psychiatry and his applied epistemology of body and self-experience	31